Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

LATACHIMO COMBINATION OPHTHALMIC SOLUTION “NITTO”

Approval Number

SIN15974P

Drug Name

LATACHIMO COMBINATION OPHTHALMIC SOLUTION “NITTO”

Product Name

LATACHIMO COMBINATION OPHTHALMIC SOLUTION “NITTO”

Approval Date

July 16, 2020

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

SOLUTION, STERILE

Route of Administration

OPHTHALMIC

Medical Information

ATC Code

S01ED51

ATC Item Name

timolol, combinations

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

Nitto Medic Co., Ltd

Active Ingredients

Ingredient Name

Latanoprost

Strength

0.05 mg/ml

Drug MonographLatanoprost

Ingredient Name

Timolol Maleate

Strength

6.83 mg/ml

Drug MonographTimolol

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

LATACHIMO COMBINATION OPHTHALMIC SOLUTION “NITTO” - HSA Approval | MedPath